Dirk Daelemans

10.4k total citations · 1 hit paper
173 papers, 5.8k citations indexed

About

Dirk Daelemans is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Dirk Daelemans has authored 173 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Infectious Diseases, 73 papers in Virology and 65 papers in Molecular Biology. Recurrent topics in Dirk Daelemans's work include HIV Research and Treatment (72 papers), HIV/AIDS drug development and treatment (69 papers) and Pneumocystis jirovecii pneumonia detection and treatment (26 papers). Dirk Daelemans is often cited by papers focused on HIV Research and Treatment (72 papers), HIV/AIDS drug development and treatment (69 papers) and Pneumocystis jirovecii pneumonia detection and treatment (26 papers). Dirk Daelemans collaborates with scholars based in Belgium, United States and China. Dirk Daelemans's co-authors include Christophe Pannecouque, Erik De Clercq, George N. Pavlakis, Stephen Lockett, Sylvain V. Costes, Edward H. Cho, Zachary C. Dobbin, Els Vanstreels, Xinyong Liu and Peng Zhan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Dirk Daelemans

166 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Automatic and Quantitative Measurement of Protein-Protein Colocalization in Live Cells

2004 1.1k citations Dirk Daelemans et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dirk Daelemans Belgium	36	2.6k	1.6k	1.3k	1.1k	914	173	5.8k
Nouara Yahi France	43	2.5k 1.0×	1.6k 1.0×	1.6k 1.2×	286 0.3×	437 0.5×	118	5.1k
Karl Y. Hostetler United States	50	3.3k 1.2×	1.4k 0.9×	1.2k 0.9×	345 0.3×	2.3k 2.6×	183	7.0k
James E. Strickler United States	31	3.4k 1.3×	823 0.5×	766 0.6×	798 0.7×	516 0.6×	47	6.1k
V.N. Malashkevich United States	34	2.4k 0.9×	673 0.4×	557 0.4×	273 0.2×	539 0.6×	65	4.1k
Timothy Spicer United States	32	1.5k 0.6×	631 0.4×	496 0.4×	382 0.3×	294 0.3×	130	3.3k
Marc Ferrer United States	43	4.0k 1.5×	568 0.4×	569 0.4×	286 0.3×	851 0.9×	201	7.1k
Antonello Pessi Italy	40	2.5k 0.9×	973 0.6×	699 0.5×	349 0.3×	1.0k 1.1×	114	5.1k
Jianping Ding China	49	7.8k 2.9×	3.5k 2.2×	3.0k 2.3×	430 0.4×	1.1k 1.1×	187	11.8k
L.F. Haire United Kingdom	30	4.9k 1.8×	804 0.5×	614 0.5×	274 0.2×	2.8k 3.1×	45	7.4k
Elisabetta Bianchi Italy	33	1.9k 0.7×	632 0.4×	534 0.4×	352 0.3×	621 0.7×	83	3.8k

Countries citing papers authored by Dirk Daelemans

Since Specialization

Citations

This map shows the geographic impact of Dirk Daelemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Daelemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Daelemans more than expected).

Fields of papers citing papers by Dirk Daelemans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Daelemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Daelemans. The network helps show where Dirk Daelemans may publish in the future.

Co-authorship network of co-authors of Dirk Daelemans

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Daelemans. A scholar is included among the top collaborators of Dirk Daelemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Daelemans. Dirk Daelemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grgić, Dajana Kučić, et al.. (2025). Biological assessments of novel ultrasound-synthesized 2-arylbenzimidazole derivatives: antiproliferative and antibacterial effects. RSC Medicinal Chemistry. 16(7). 3197–3212. 1 indexed citations

Vos, Kristof De, Justina C. Wolters, Susan Schlenner, et al.. (2024). Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells. Biochemical Pharmacology. 227. 116445–116445. 1 indexed citations

Laat, Vincent de, Xander Spotbeen, Ali Talebi, et al.. (2024). Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer. Nature Communications. 15(1). 8540–8540. 6 indexed citations

Vanmeerbeek, Isaure, Stefan Naulaerts, Jenny Sprooten, et al.. (2024). Targeting conserved TIM3 ⁺ VISTA ⁺ tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science Advances. 10(29). eadm8660–eadm8660. 22 indexed citations

Persoons, Leentje, et al.. (2023). Synthesis and Antiproliferative Activity of 2,6-Disubstituted Imidazo[4,5-b]pyridines Prepared by Suzuki Cross Coupling. Molecules. 28(20). 7208–7208.

Salman, Abbas Washeel, et al.. (2023). New sugar-incorporated N-heterocyclic carbene precursors and their Ag(I) and Pd(II) complexes: Synthesis, characterization, and cytotoxicity studies. Journal of Molecular Liquids. 393. 123618–123618. 2 indexed citations

Vercruysse, Thomas, et al.. (2022). Cellular Stress Induces Nucleocytoplasmic Transport Deficits Independent of Stress Granules. Biomedicines. 10(5). 1057–1057. 6 indexed citations

Helsen, Christine, et al.. (2022). The T850D Phosphomimetic Mutation in the Androgen Receptor Ligand Binding Domain Enhances Recruitment at Activation Function 2. International Journal of Molecular Sciences. 23(3). 1557–1557. 4 indexed citations

Huang, Boshi, Tiziana Ginex, F. Javier Luque, et al.. (2021). Structure-Based Design and Discovery of Pyridyl-Bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling Studies. Journal of Medicinal Chemistry. 64(18). 13604–13621. 13 indexed citations

10.

Rapino, Francesca, Kevin Rouault‐Pierre, Joan Somja, et al.. (2021). Loss of tRNA-modifying enzyme Elp3 activates a p53-dependent antitumor checkpoint in hematopoiesis. The Journal of Experimental Medicine. 218(3). 17 indexed citations

11.

Neggers, Jasper E., Maarten Jacquemyn, Tim Dierckx, et al.. (2020). enAsCas12a Enables CRISPR-Directed Evolution to Screen for Functional Drug Resistance Mutations in Sequences Inaccessible to SpCas9. Molecular Therapy. 29(1). 208–224. 13 indexed citations

12.

Huang, Boshi, Zhuo Li, Zhao Wang, et al.. (2020). Discovery of potential dual-target prodrugs of HIV-1 reverse transcriptase and nucleocapsid protein 7. Bioorganic & Medicinal Chemistry Letters. 30(16). 127287–127287. 3 indexed citations

13.

Azmi, Asfar S., Husain Yar Khan, Irfana Muqbil, et al.. (2019). Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 26(6). 1338–1348. 40 indexed citations

14.

Kang, Dongwei, Zhao Wang, Heng Zhang, et al.. (2018). Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery. ACS Medicinal Chemistry Letters. 9(4). 370–375. 29 indexed citations

15.

Neggers, Jasper E., Tim Dierckx, Hiroki Noguchi, et al.. (2018). Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes. Nature Communications. 9(1). 502–502. 78 indexed citations

16.

Gevaert, Thomas, Els Vanstreels, Dirk Daelemans, et al.. (2017). The stem cell growth factor receptor KIT is not expressed on interstitial cells in bladder. European Urology Supplements. 16(3). e355–e355. 2 indexed citations

17.

Kang, Dongwei, Xiao Ding, Gaochan Wu, et al.. (2017). Discovery of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the Tolerant Region I of NNIBP. ACS Medicinal Chemistry Letters. 8(11). 1188–1193. 29 indexed citations

18.

Kang, Dongwei, Zengjun Fang, Boshi Huang, et al.. (2017). Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants. Journal of Medicinal Chemistry. 60(10). 4424–4443. 84 indexed citations

19.

Zhou, Zhongxia, Tao Liu, Dongwei Kang, et al.. (2017). Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored “hydrophobic channel”. Organic & Biomolecular Chemistry. 16(6). 1014–1028. 26 indexed citations

20.

Vercruysse, Thomas, Jolien De Bie, Jasper E. Neggers, et al.. (2016). The Second-Generation Exportin-1 Inhibitor KPT-8602 Demonstrates Potent Activity against Acute Lymphoblastic Leukemia. Clinical Cancer Research. 23(10). 2528–2541. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact